Delivery Order SPE2DB22D9239-SPE2DB24FDK07
Award Date 6/2/24
Potential Completion Date 6/24/24
Potential Value $118K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $34,500.76, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued up to $499,999,999, that allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $24,724.65, is for the delivery of Entyvio 300 mg vials, a pharmaceutical product, with a performance period through May 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and DLA, valued at $499,999,999 and valid through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,473.84, is for the supply of Entyvio 300 mg vials, a biologic medication. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $147,860.40 contract is for the delivery of Entyvio 300 mg vials, a biologic medication, to support the recurring pharmaceutical supply needs of military health facilities. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to...
- The Defense Logistics Agency (DLA) awarded a $115,494.24 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Entyvio 300 mg vials. This order is being fulfilled under a larger indefinite delivery contract with DMS Pharmaceutical Group to provide a variety of pharmaceutical and medical products to support the operations of military treatment facilities worldwide. The contract does not have a set-aside designation and is...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $29,572.08 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Entyvio 300 mg vials, a biologic medication used to treat certain inflammatory bowel diseases. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $4,944.93, is for the delivery of Entyvio 300 mg vials. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC enables the DLA to issue delivery orders for a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at up to $115,494.24, is for the delivery of Entyvio 300 mg vials. The contract has no set-aside designation. This delivery order is part of a larger single-award Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA, valued at up to $499,999,999 and running through December 31, 2025....
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Entyvio 300 mg vials. The contract has a potential value of $29,572.08 and a completion date of February 16, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds a larger indefinite delivery contract with DLA, valued up to $4,999,999 through 2025, to supply a wide range of pharmaceutical products to military...
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $39,429.44, is to provide Entyvio 300 mg vials to support the recurring pharmaceutical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS...